About
Basic Data Updated:
1 month agoAlivira Animal Health Limited, as stated in its credit rating report, is involved in the production of veterinary APIs and formulations. The company boasts a wide range of 23 commercial products in the field of animal health APIs and an impressive 450 products spanning across 12 different dosage forms. These products are manufactured in seven state-of-the-art facilities located in various countries such as India, Spain, Turkey, Brazil, and Germany. Among the diverse range of products offered by AAHL are feed supplements, antibiotics, anthelmintics, antibacterial agents, skincare (dermatology) products, and disinfectants, to name a few.
Industry
Company Details
- Location
Thane, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U74120MH2013PLC248708 |
| Company No. | 248708 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 30 Sep 2013 |
| Date of AGM | 30 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Products or Services related to Alivira Animal Health Limited
Veterinary Medicines
Animal Treatment Services
Financials of Alivira Animal Health Limited
Alivira Animal Health Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.69% increase. The company also saw a substantial fall in profitability, with a 53.21% decrease in profit. The company's net worth moved up by a moderate rise of 5.57%.
Corporate Structure
Unlock access to Alivira Animal Health's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Alivira Animal Health Limited
Unlock and access historical data on people associated with Alivira Animal Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
Rajaram Narayanan
Managing DirectorAppointment Date: 11-Apr-2022
Status: Current
SN
Sharat Narasapur Managing DirectorAppointment Date: 08-Jan-2017
Status: Current
SB
Saurav Bhala CFOStatus: Current
ND
Nihar Das Company SecretaryAppointment Date: 25-Jun-2022
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 07 Dec 2022 | ₹49.40 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 07 Dec 2022 | ₹159.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 27 Jul 2021 | ₹15.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alivira Animal Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alivira Animal Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Sequent Scientific Limited
Active
38 years 11 months Kamal Sharma, Sharat Narasapur and 2 more are mutual person
Sequent Research Limited
Active 17 years 1 month Sharat Narasapur and Rajaram Narayanan are mutual person
Recent activity within the organization
Director Appointment
Vedprakash Shantalingappa Ragate was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2024 & has been associated with this company since 1 month 21 days .
11 Apr 2024Annual General Meeting
Alivira Animal Health Limited last Annual general meeting of members was held on 30 Aug 2023 as per latest MCA records.
30 Aug 2023Balance Sheet
Alivira Animal Health Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge with Citi Bank N.A. amounted to Rs. 49.40 cr with Charge ID 100652625 was registered on 07 Dec 2022.
07 Dec 2022Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 159.00 cr with Charge ID 100655129 was registered on 07 Dec 2022.
07 Dec 2022
Recent News, Updates & Announcement
Cadila Healthcare Divests its Entire Stake in Bremer Pharma.Medicalbuyer 20 Apr 2018
- SeQuent Scientific arm buys Cadilas animal health biz in Germany.
VCCircle 18 Apr 2018
- SeQuent Scientific arm Alivira registers 3 products in Ukraine.
Drug firm SeQuent Scientific today said its animal healthcare arm Alivira has received approval for registration of three products in Ukraine.
DNA India 04 Jul 2017
- Aliviras animal health API facility gets US FDA approval.
Business Standard 02 May 2017
Frequently asked questions
What is the Incorporation or founding date of Alivira Animal Health Limited?
